<

 
Data updated 2024-09-19 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date04716493.4 (espacenet)  (Federated)  (European Patent Register), 20040302
Patent/reg. no. and dateDK/EP 1604203, 20091028
Publication date20051214
Priority no. and dateUS 384066, 20030307
EP pub. no. and date EP 1604203 20051214
Effective date
Applicant/ownerSociété des Produits Nestlé S.A., Entre-deux-Villes
1800 Vevey, CH
Applicant ref. no.P003024EPDK1
InventorRICHERSON, Russell, 5050 East Gleneagles Drive
Tucson, AZ 85718, US,
DERVIEUX, Thierry, 4905 Enfield Avenue
Encino, CA 91316, US
RepresentativeCHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK
Opponent
IPC ClassA01N 1/02 (2006.01) , C12Q 1/00 (2006.01) , C12Q 1/02 (2006.01) , G01N 21/62 (2006.01) , G01N 21/75 (2006.01) , G01N 30/02 (2006.01) , G01N 33/00 (2006.01) , G01N 33/48 (2006.01) 
TitleFremgangsmåde til direkte bestemmelse af individuelle methotrexatmeta-bolitter
Int. application no.US2004006312
Int. publication no.WO2004081521
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact